Published in Clin Exp Immunol on March 01, 1982
Cellular receptor for 125I-labeled tumor necrosis factor: specific binding, affinity labeling, and relationship to sensitivity. Proc Natl Acad Sci U S A (1985) 2.92
Malarial parasites and tumour cells are killed by the same component of tumour necrosis serum. Clin Exp Immunol (1984) 2.34
Tumour necrosis factor in man: clinical and biological observations. Br J Cancer (1987) 1.46
Necrosin: purification and properties of a cytotoxin derived from a murine macrophage-like cell line. Proc Natl Acad Sci U S A (1984) 1.19
Anti-tumour cytotoxin from macrophages: no correlation between cytotoxin adsorption by tumour cell lines and their cytotoxin susceptibility. Immunology (1984) 0.78
An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A (1975) 23.42
Purification and physico-chemical characterization of rabbit tumor necrosis factor. J Immunol (1980) 4.98
Tumour-necrosis factor from the rabbit. I. Mode of action, specificity and physicochemical properties. Br J Cancer (1978) 3.38
Endotoxin-induced serum factor kills malarial parasites in vitro. Infect Immun (1981) 2.30
Subclasses of T cells with different sensitivities to cytotoxic antibody in the presence of anesthetics. Eur J Immunol (1975) 1.94
Rabbit tumor necrosis factor: mechanism of action. Infect Immun (1981) 1.62
Induction and immunological properties of tumor necrosis factor. J Reticuloendothel Soc (1978) 1.53
Human fetal thymus and bone marrow contain target cells for natural killer cells. Eur J Immunol (1981) 1.51
Lymphotoxin. A review and analysis. Am J Pathol (1976) 1.05
Increased hepatotoxicity of bacterial lipopolysaccharide in mice infected with Schistosoma mansoni. Parasite Immunol (1979) 0.96
The cellular basis of immunological responses. A synthesis of some current views. Lancet (1969) 6.05
Focal antibody production by transferred spleen cells in irradiated mice. Science (1965) 3.12
Lipoarabinomannan from Mycobacterium tuberculosis induces the production of tumour necrosis factor from human and murine macrophages. Clin Exp Immunol (1989) 3.09
Strain differences in the immune response of mice. I. The neonatal response to sheep red cells. Immunology (1968) 2.98
The role of gamma-interferon, vitamin D3 metabolites and tumour necrosis factor in the pathogenesis of tuberculosis. Immunology (1987) 2.91
Interactions of TRIC agents with macrophages and BHK-21 cells observed by electron microscopy. J Hyg (Lond) (1973) 2.85
Cultivation of TRIC agents: a comparison between the use of BHK-21 and irradiated McCoy cells. J Hyg (Lond) (1974) 2.66
Immunosuppression in murine malaria. I. General characteristics. Clin Exp Immunol (1971) 2.56
Malarial parasites induce TNF production by macrophages. Immunology (1988) 2.42
Malarial parasites and tumour cells are killed by the same component of tumour necrosis serum. Clin Exp Immunol (1984) 2.34
Endotoxin-induced serum factor kills malarial parasites in vitro. Infect Immun (1981) 2.30
Induction of red cell autoantibodies in normal mice. Nat New Biol (1973) 2.09
Malaria: phosphatidylserine expression is not increased on the surface of parasitized erythrocytes. Parasitol Today (1995) 2.05
Protection of mice against malaria by a killed vaccine: differences in effectiveness against P. yoelii and P. berghei. Immunology (1977) 2.03
Immunosuppressive potency and in-vitro activity of antilymphocyte globulin. Lancet (1969) 2.02
Cell cooperation in the immune response. Clin Exp Immunol (1971) 1.91
Cell-mediated immunity in mice vaccinated against malaria. Clin Exp Immunol (1978) 1.82
Differential sensitivity in vivo of lethal and nonlethal malarial parasites to endotoxin-induced serum factor. Infect Immun (1982) 1.79
Suppressor T cells in experimental autoimmune haemolytic anaemia. Nature (1978) 1.79
Separate thymus dependent and thymus independent antibody forming cell precursors. Nat New Biol (1971) 1.78
Tumour necrosis factor induction by malaria exoantigens depends upon phospholipid. Immunology (1992) 1.78
Soluble malarial antigens are toxic and induce the production of tumour necrosis factor in vivo. Immunology (1989) 1.77
Killing of human malaria parasites by macrophage secretory products. Infect Immun (1984) 1.76
Early gamma interferon responses in lethal and nonlethal murine blood-stage malaria. Infect Immun (1997) 1.75
Killing of blood-stage murine malaria parasites by hydrogen peroxide. Infect Immun (1983) 1.74
The malaria vaccine: anti-parasite or anti-disease? Immunol Today (1990) 1.74
Immunopathology of cerebral malaria: morphological evidence of parasite sequestration in murine brain microvasculature. Infect Immun (2000) 1.70
The role of antibody in T-cell responses. Clin Exp Immunol (1974) 1.67
The role of the liver in immunity to blood-stage murine malaria. Immunology (1980) 1.65
Cell-mediated immunity in the liver of mice vaccinated against malaria. Nature (1979) 1.64
Strain differences in the behavior of TRIC agnets in cell cultures. Am J Ophthalmol (1967) 1.62
Recombinant tumour necrosis factor inhibits malaria parasites in vivo but not in vitro. Clin Exp Immunol (1987) 1.62
Rosette formation by mouse lymphocytes. III. Receptors for immunoglobulin on normal and activated T cells. Clin Exp Immunol (1974) 1.59
Strain differences in the immune responses of mice. 3. A raised tolerance threshold in NZB thymus cells. Immunology (1971) 1.57
Specific tolerance to sheep erythrocytes in mouse bone marrow cells. Nature (1969) 1.52
Expression and rescuing of a cloned human tumour necrosis factor gene using an EBV-based shuttle cosmid vector. EMBO J (1987) 1.48
Response of mouse T and B lymphocytes to sheep erythrocytes. Nat New Biol (1972) 1.45
Strain differences in the immune response of mice. II. Responses by neonatal cells in irradiated adult hosts. Immunology (1968) 1.45
Interactions of TRIC agents with macrophages: effects on lysosomal enzymes of the cell. J Hyg (Lond) (1974) 1.43
Recombinant gamma interferon is a potent adjuvant for a malaria vaccine in mice. Clin Exp Immunol (1987) 1.42
Response to phytohaemagglutinin of lymphocytes from mice treated with anti-lymphocyte globulin. Immunology (1969) 1.41
Human and murine macrophages produce TNF in response to soluble antigens of Plasmodium falciparum. Parasite Immunol (1990) 1.40
Rosette formation by mouse lymphocytes. II. T-cell specificities in a CRL subpopulation. Clin Exp Immunol (1974) 1.39
Indirect immunofluorescence of mouse thymus-derived cells using heterologous anti-brain serum. Cell Immunol (1973) 1.38
Reactivity and crossreactivity of mouse helper T cells to malaria parasites. Immunology (1977) 1.36
Some consequences of the multiple infection of cell cultures by TRIC organisms. J Hyg (Lond) (1972) 1.36
Malaria exoantigens induce T-independent antibody that blocks their ability to induce TNF. Immunology (1990) 1.35
Killing of the malarial parasite Plasmodium yoelii in vitro by cells of myeloid origin. Parasite Immunol (1982) 1.34
Antibody responses in mice protected against malaria by vaccination. Parasite Immunol (1979) 1.34
Immunity to malaria. Br Med Bull (1982) 1.34
Antibody formation by bone marrow cells in irradiated mice. I. Thymus-dependent and thymus-independent responses to sheep erythrocytes. Immunology (1971) 1.31
Neutralization of TRIC organisms by antibody: enhancement by antisera prepared against immunoglobulins. J Hyg (Lond) (1974) 1.31
Syngeneic splenomegaly in NZB and BALB-c mice. Transplantation (1969) 1.30
Spontaneously arising cytotoxicity to the P-815-Y mastocytoma in NZB mice. Clin Exp Immunol (1974) 1.27
The genetic basis of autoimmunity in NZB mice studied by progeny-testing. Clin Exp Immunol (1971) 1.24
Antibodies against phosphatidylinositol and inositol monophosphate specifically inhibit tumour necrosis factor induction by malaria exoantigens. Immunology (1992) 1.23
Two soluble antigens of Plasmodium falciparum induce tumor necrosis factor release from macrophages. Infect Immun (1990) 1.21
Vaccination of mice against malaria with soluble antigens. I. The effect of detergent, route of injection, and adjuvant. Parasite Immunol (1986) 1.20
Anaemia and resistance to malaria in transgenic mice expressing human tumour necrosis factor. Immunology (1994) 1.19
Rosette formation by mouse lymphocytes. I. Demonstration by indirect immunofluorescence of T cells binding sheep erythrocytes. Clin Exp Immunol (1974) 1.17
Specific monoclonal IgM is a potent adjuvant in murine malaria vaccination. Nature (1983) 1.15
Stimulation and suppression of response of mouse T cells to the schistosomules of Schistosoma mansoni during infection. Nature (1976) 1.14
Two distinct types of non-specific immunosuppression in murine malaria. Clin Exp Immunol (1980) 1.14
Serum IL-2 inhibitor in mice. I. Increase during infection. Immunology (1985) 1.14
Age-dependent changes in the relative affinity of anti-dinitrophenyl antibodies in mice. Immunology (1975) 1.13
B cells: subpopulations, tolerance, autoimmunity, and infection. Immunol Rev (1979) 1.13
Lymphocyte traffic and lymphocyte destruction in murine malaria. Immunology (1982) 1.13
Macrophage cytotoxicity in lethal and non-lethal murine malaria and the effect of vaccination. Clin Exp Immunol (1986) 1.12
Vaccination with a purified blood-stage malaria antigen in mice: correlation of protection with T cell mediated immunity. Clin Exp Immunol (1985) 1.12
Differential involvement of non-specific suppressor T cells in two lethal murine malaria infections. Clin Exp Immunol (1981) 1.11
Killing of Plasmodium yoelii by enzyme-induced products of the oxidative burst. Infect Immun (1984) 1.10
Detoxified exoantigens and phosphatidylinositol derivatives inhibit tumor necrosis factor induction by malarial exoantigens. Infect Immun (1992) 1.10
Malaria toxins: hypoglycaemia and TNF production are induced by different components. Parasitol Today (1995) 1.10
Malaria toxins: TNF-mediated phenomena. Parasitol Today (1996) 1.09
Malaria exoantigens induce TNF, are toxic and are blocked by T-independent antibody. Immunol Lett (1990) 1.09
Macrophages as effector cells in immunity to malaria. Immunol Lett (1985) 1.09
Changes in the capacity of macrophages and T cells to produce interleukins during murine malaria infection. Cell Immunol (1984) 1.06
Glycosylphosphatidylinositols in malaria pathogenesis and immunity: potential for therapeutic inhibition and vaccination. Curr Top Microbiol Immunol (2005) 1.05
Anti-lymphocyte antibodies in lethal mouse malaria. II. Induction of an autoantibody specific suppressor T cell by non-lethal P. yoelii. Clin Exp Immunol (1983) 1.04